Filipek B - Search Results

1

[Pharmacotherapy of Parkinson's disease: progress or regress?].

Pytka K, Zygmunt M, Filipek B. Pytka K, et al. Among authors: filipek b. Postepy Hig Med Dosw (Online). 2013 Jul 24;67:700-8. doi: 10.5604/17322693.1059684. Postepy Hig Med Dosw (Online). 2013. PMID: 24018435 Free article. Review. Polish.

2

Structure-activity relationship of some new anti-arrhythmic phenytoin derivatives.

Ciechanowicz-Rutkowska M, Stadnicka K, Kiec-Kononowicz K, Byrtus H, Filipek B, Zygmunt M, Maciag D. Ciechanowicz-Rutkowska M, et al. Among authors: filipek b. Arch Pharm (Weinheim). 2000 Nov;333(11):357-64. doi: 10.1002/1521-4184(200011)333:11<357::aid-ardp357>3.0.co;2-z. Arch Pharm (Weinheim). 2000. PMID: 11129977

3

Synthesis and properties of 2-(4-substituted)butyl derivatives of some 2,3-dihydro-1,3-dioxo-1H-pyrrolo[3,4-c]pyridines.

Sladowska H, Szkatuła D, Filipek B, Maciag D, Sapa J, Zygmunt M. Sladowska H, et al. Among authors: filipek b. Pharmazie. 2001 Feb;56(2):133-8. Pharmazie. 2001. PMID: 11234340

4

Effect of oxovanadium(IV) complexes on nondiabetic and streptozotocin-diabetic rats.

Krosniak M, Zachwieja Z, Filipek B, Zygmunt M, Grybos R. Krosniak M, et al. Among authors: filipek b. Arch Pharm (Weinheim). 2001 Dec;334(12):388-92. doi: 10.1002/1521-4184(200112)334:12<388::AID-ARDP388>3.0.CO;2-9. Arch Pharm (Weinheim). 2001. PMID: 11852534

5

Synthesis, antiarrhythmic, and antihypertensive effects of novel 1-substituted pyrrolidin-2-one and pyrrolidine derivatives with adrenolytic activity.

Malawska B, Kulig K, Filipek B, Sapa J, Maciag D, Zygmunt M, Antkiewicz-Michaluk L. Malawska B, et al. Among authors: filipek b. Eur J Med Chem. 2002 Mar;37(3):183-95. doi: 10.1016/s0223-5234(01)01321-6. Eur J Med Chem. 2002. PMID: 11900863

6

Synthesis, structure and antiarrhythmic properties evaluation of new basic derivatives of 5,5-diphenylhydantoin.

Kieć-Kononowicz K, Stadnicka K, Mitka A, Pekala E, Filipek B, Sapa J, Zygmunt M. Kieć-Kononowicz K, et al. Among authors: filipek b. Eur J Med Chem. 2003 Jun;38(6):555-66. doi: 10.1016/s0223-5234(03)00075-8. Eur J Med Chem. 2003. PMID: 12832127

7

Synthesis and evaluation of in vivo activity of diphenylhydantoin basic derivatives.

Dylag T, Zygmunt M, Maciag D, Handzlik J, Bednarski M, Filipek B, Kieć-Kononowicz K. Dylag T, et al. Among authors: filipek b. Eur J Med Chem. 2004 Dec;39(12):1013-27. doi: 10.1016/j.ejmech.2004.05.008. Eur J Med Chem. 2004. PMID: 15571863

8

Synthesis and cardiovascular activity of new 8-alkylamino-1,3-dimethyl-7-(2-hydroxy-3- piperazinopropyl)-3,7-dihydro-1H-purine-2,6-diones.

Chłoń-Rzepa G, Pawłowski M, Zygmunt M, Filipek B, Maciag D. Chłoń-Rzepa G, et al. Among authors: filipek b. Pol J Pharmacol. 2004 Nov-Dec;56(6):755-66. Pol J Pharmacol. 2004. PMID: 15662088 Free article.

9

Synthesis, structure-activity relationship of some new anti-arrhythmic 5-arylidene imidazolidine-2,4-dione derivatives.

Pekala E, Stadnicka K, Broda A, Zygmunt M, Filipek B, Kieć-Kononowicz K. Pekala E, et al. Among authors: filipek b. Eur J Med Chem. 2005 Mar;40(3):259-69. doi: 10.1016/j.ejmech.2004.11.006. Epub 2005 Jan 19. Eur J Med Chem. 2005. PMID: 15725495

10

Antiparkinsonian effects of novel adenosine A(2A) receptor antagonists.

Drabczyńska A, Zygmunt M, Sapa J, Filipek B, Müller CE, Kieć-Kononowicz K. Drabczyńska A, et al. Among authors: filipek b. Arch Pharm (Weinheim). 2011 Jan;344(1):20-7. doi: 10.1002/ardp.201000124. Epub 2010 Nov 18. Arch Pharm (Weinheim). 2011. PMID: 21213348

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page